AU2016204393A1 - Method for treating multiple sclerosis - Google Patents

Method for treating multiple sclerosis Download PDF

Info

Publication number
AU2016204393A1
AU2016204393A1 AU2016204393A AU2016204393A AU2016204393A1 AU 2016204393 A1 AU2016204393 A1 AU 2016204393A1 AU 2016204393 A AU2016204393 A AU 2016204393A AU 2016204393 A AU2016204393 A AU 2016204393A AU 2016204393 A1 AU2016204393 A1 AU 2016204393A1
Authority
AU
Australia
Prior art keywords
antibody
exposure
dose
patient
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016204393A
Other languages
English (en)
Inventor
Peter S. Chin
Hideki Garren
David Leppert
Anne-Marie Li-Kwai-Cheung
Michele Libonati
Donna Masterman
Jean-Paul Pfefen
Craig Smith
Algirdas Jonas Kakarieka Weisskopf
Jiameng Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2016204393A1 publication Critical patent/AU2016204393A1/en
Assigned to GENENTECH, INC. reassignment GENENTECH, INC. Request for Assignment Assignors: CHIN, PETER S., GARREN, HIDEKI, LEPPERT, DAVID, LIBONATI, MICHELE, LI-KWAI-CHEUNG, ANNE-MARIE, MASTERMAN, DONNA, PFEFEN, JEAN-PAUL, SMITH, CRAIG, WEISSKOPF, ALGIRDAS JONAS KAKARIEKA, ZHANG, JIAMENG
Priority to AU2022228198A priority Critical patent/AU2022228198B9/en
Priority to AU2025279711A priority patent/AU2025279711A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016204393A 2015-10-06 2016-06-27 Method for treating multiple sclerosis Abandoned AU2016204393A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022228198A AU2022228198B9 (en) 2015-10-06 2022-09-09 Method for treating multiple sclerosis
AU2025279711A AU2025279711A1 (en) 2015-10-06 2025-12-11 Method for treating multiple sclerosis

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US201562238103P 2015-10-06 2015-10-06
US62/238,103 2015-10-06
US201562238674P 2015-10-07 2015-10-07
US62/238,674 2015-10-07
US201562271985P 2015-12-28 2015-12-28
US62/271,985 2015-12-28
US201662296049P 2016-02-16 2016-02-16
US62/296,049 2016-02-16
US201662322734P 2016-04-14 2016-04-14
US62/322,734 2016-04-14
US201662342633P 2016-05-27 2016-05-27
US62/342,633 2016-05-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022228198A Division AU2022228198B9 (en) 2015-10-06 2022-09-09 Method for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
AU2016204393A1 true AU2016204393A1 (en) 2017-04-20

Family

ID=58468383

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2016204393A Abandoned AU2016204393A1 (en) 2015-10-06 2016-06-27 Method for treating multiple sclerosis
AU2022228198A Active AU2022228198B9 (en) 2015-10-06 2022-09-09 Method for treating multiple sclerosis
AU2025279711A Pending AU2025279711A1 (en) 2015-10-06 2025-12-11 Method for treating multiple sclerosis

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2022228198A Active AU2022228198B9 (en) 2015-10-06 2022-09-09 Method for treating multiple sclerosis
AU2025279711A Pending AU2025279711A1 (en) 2015-10-06 2025-12-11 Method for treating multiple sclerosis

Country Status (3)

Country Link
AU (3) AU2016204393A1 (https=)
CA (1) CA2934069A1 (https=)
MX (1) MX2016008541A (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR073295A1 (es) * 2008-09-16 2010-10-28 Genentech Inc Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.

Also Published As

Publication number Publication date
AU2022228198A1 (en) 2022-11-24
AU2022228198B9 (en) 2025-09-25
AU2025279711A1 (en) 2026-01-15
AU2022228198B1 (https=) 2025-09-11
CA2934069A1 (en) 2017-04-06
MX2016008541A (es) 2017-12-26

Similar Documents

Publication Publication Date Title
US20250171551A1 (en) Methods for treating progressive multiple sclerosis
AU2005249566B2 (en) Method for treating multiple sclerosis
US20240327536A1 (en) Method for treating multiple sclerosis
AU2025279711A1 (en) Method for treating multiple sclerosis

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: GENENTECH, INC.

Free format text: FORMER APPLICANT(S): MASTERMAN, DONNA; CHIN, PETER S.; LIBONATI, MICHELE; LEPPERT, DAVID; ZHANG, JIAMENG; PFEFEN, JEAN-PAUL; WEISSKOPF, ALGIRDAS JONAS KAKARIEKA; SMITH, CRAIG; LI-KWAI-CHEUNG, ANNE-MARIE; GARREN, HIDEKI

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted